Effects of losartan and simvastatin on monocyte-derived microparticles in hypertensive patients with and without type 2 diabetes mellitus

被引:80
作者
Nomura, S
Shouzu, A
Omoto, S
Nishikawa, M
Iwasaka, T
机构
[1] Kansai Med Univ, Dept Internal Med 1, Moriguchi, Osaka 5708507, Japan
[2] Kansai Med Univ, Dept Internal Med 2, Moriguchi, Osaka 5708507, Japan
关键词
monocyte; derived microparticle; type 2 diabetes mellitus; hypertension; angiotensin II receptor blocker; statin;
D O I
10.1177/107602960401000203
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Monocyte-derived microparticles play an important role in the pathogenesis of diabetic vasculopathy, and angiotensin II receptor blocker and statin have been shown to have a beneficial effect on the angiopathies of hypertension and hyperglycemia in patients with type 2 diabetes mellitus. However, the interaction between angiotensin II receptor blocker and statin, and monocyte-derived microparticles in atherosclerosis is poorly understood. The effects of losartan and simvastatin on circulating concentrations of monocyte-derived microparticles, chemokines, and soluble adhesion markers were studied in hypertensive patients with or without type 2 diabetes mellitus. Monocyte-derived microparticles were measured by flow cytometry, and levels of serum chemokines (MCP-1 and RANTES) and soluble adhesion markers (sP-selectin and sVCAM-1) were measured by enzyme-linked immunosorbent assay. Losartan decreased both the systolic and diastolic blood pressure in hypertensive patients with and without type 2 diabetes mellitus. The concentrations of monocyte-derived microparticles, chemokines, and soluble adhesion molecules were higher in hypertensive patients who also had type 2 diabetes mellitus vs. those who did not. The administration of angiotensin II receptor blocker decreased the circulating concentration of all these markers. In addition, all markers were decreased by combination therapy, and monocyte-derived microparticles were decreased more with combination therapy with losartan and simvastatin than monotherapy with losartan. The administration of angiotensin II receptor blocker inhibited monocyte-derived microparticle generation and suggests that angiotensin II is intimately related to vascular changes that occur in type 2 diabetes mellitus. Combination therapy with a statin and angictensin II receptor blocker might be valuable as anti-atherosclerotic therapy in patients with type 2 diabetes mellitus and nephropathy.
引用
收藏
页码:133 / 141
页数:9
相关论文
共 53 条
[1]   LEUKOCYTE-ENDOTHELIAL INTERACTIONS AND REGULATION OF LEUKOCYTE MIGRATION [J].
ADAMS, DH ;
SHAW, S .
LANCET, 1994, 343 (8901) :831-836
[2]   MONOCYTE ADHERENCE TO HUMAN VASCULAR ENDOTHELIUM [J].
BEEKHUIZEN, H ;
VANFURTH, R .
JOURNAL OF LEUKOCYTE BIOLOGY, 1993, 54 (04) :363-378
[3]   ENDOTHELIAL-LEUKOCYTE ADHESION MOLECULES IN HUMAN-DISEASE [J].
BEVILACQUA, MP ;
NELSON, RM ;
MANNORI, G ;
CECCONI, O .
ANNUAL REVIEW OF MEDICINE, 1994, 45 :361-378
[4]   COAGULATION AND FIBRINOLYTIC SYSTEM IMPAIRMENT IN INSULIN-DEPENDENT DIABETES-MELLITUS [J].
CARMASSI, F ;
MORALE, M ;
PUCCETTI, R ;
DENEGRI, F ;
MONZANI, F ;
NAVALESI, R ;
MARIANI, G .
THROMBOSIS RESEARCH, 1992, 67 (06) :643-654
[5]   Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation - Effects of short- and long-term simvastatin treatment [J].
Ceriello, A ;
Taboga, C ;
Tonutti, L ;
Quagliaro, L ;
Piconi, L ;
Bais, B ;
Da Ros, R ;
Motz, E .
CIRCULATION, 2002, 106 (10) :1211-1218
[6]   Losartan, an angiotensin type 1 receptor antagonist, improves endothelial function in non-insulin-dependent diabetes [J].
Cheetham, C ;
Collis, J ;
O'Driscoll, G ;
Stanton, K ;
Taylor, R ;
Green, D .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (05) :1461-1466
[7]  
Chen XL, 1998, CIRC RES, V83, P952
[8]   Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia effects of statin therapy [J].
Cipollone, F ;
Mezzetti, A ;
Porreca, E ;
Di Febbo, C ;
Nutini, M ;
Fazia, M ;
Falco, A ;
Cuccurullo, F ;
Davì, G .
CIRCULATION, 2002, 106 (04) :399-402
[9]   E-selectin plasma concentration is influenced by glycaemic control in NIDDM patients: Possible role of oxidative stress [J].
Cominacini, L ;
Fratta Pasini, A ;
Garbin, U ;
Campagnola, M ;
Davoli, A ;
Rigoni, A ;
Zenti, MG ;
Pastorino, AM ;
LoCascio, V .
DIABETOLOGIA, 1997, 40 (05) :584-589
[10]   Relationship between ethnicity and glycemic control, lipid profiles, and blood pressure during the first 9 years of type 2 diabetes - UK prospective diabetes study (UKPDS 55) [J].
Davis, TME ;
Cull, CA ;
Holman, RR .
DIABETES CARE, 2001, 24 (07) :1167-1174